Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.
about
Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cellsLong-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients.Effects of conditioned medium from LL-37 treated adipose stem cells on human fibroblast migration.
P2860
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plerixafor (a CXCR4 antagonist ...... hances hematopoietic recovery.
@en
Plerixafor
@nl
type
label
Plerixafor (a CXCR4 antagonist ...... hances hematopoietic recovery.
@en
Plerixafor
@nl
prefLabel
Plerixafor (a CXCR4 antagonist ...... hances hematopoietic recovery.
@en
Plerixafor
@nl
P2093
P2860
P1476
Plerixafor (a CXCR4 antagonist ...... hances hematopoietic recovery.
@en
P2093
Alice Mims
Anthony D Sung
Ari Horwitz
Cristina Gasparetto
David Rizzieri
Gwynn Long
Jagadish Kummetha Venkata
Kelly Corbet
Luciano Costa
Michael M B Green
P2860
P2888
P356
10.1186/S13045-016-0301-2
P577
2016-08-17T00:00:00Z
P6179
1044449917